Antidepressant News and Research

RSS

Antidepressants are medicines that treat depression. Your doctor can prescribe them for you. They can improve your mood, sleep, appetite and concentration. It may take several weeks for them to help. There are several types of antidepressants. You and your doctor may have to try several before finding what works best for you.

Healthy gut microbiota contributes to normal brain function, study shows

Depression is a mental disorder that affects more than 264 million people of all ages worldwide. Understanding its mechanisms is vital for the development of effective therapeutic strategies.

11 Dec 2020

Researchers assess benefits of magnetic seizure therapy to treat depression in bipolar patients

Researchers are assessing whether magnetic seizure therapy (MST) can help relieve treatment-resistant depression in bipolar patients in a clinical trial led by The University of Texas Health Science Center at Houston (UTHealth).

24 Nov 2020

Antidepressant may prevent worsening of COVID-19 infection, study suggests

The antidepressant fluvoxamine appears to prevent COVID-19 infections from worsening and may help keep patients out of the hospital, a trial based on research from the University of Virginia School of Medicine suggests.

15 Nov 2020

Antidepressant drug fluvoxamine may prevent some serious complications of COVID-19

In a preliminary study of COVID-19 patients with mild-to-moderate disease who were attempting to recover in their homes, researchers at Washington University School of Medicine in St. Louis have found that the drug fluvoxamine seems to prevent some of the most serious complications of the illness and make hospitalization and the need for supplemental oxygen less likely.

12 Nov 2020

Targeting TAAR5 can provide a new treatment opportunity for neurodegenerative disorders

St Petersburg University researchers, led by Professor Raul R. Gainetdinov, Director of the Institute of Translational Biomedicine and Academic Supervisor of the St Petersburg University Hospital, have found a new role for recently discovered neurotransmitter system that uses the trace amine-associated receptor 5 (TAAR5) for neurotransmission.

11 Nov 2020

Delirium common after hospital discharge in critically ill COVID-19 patients

Anesthesiologist and other researchers from Michigan Medicine, Ann Arbor, New York Medical College, Valhalla and Center for Consciousness Science, University of Michigan Medical School, Ann Arbor, have reported a case series of critically ill coronavirus disease 2019 (COVID-19) patients who have developed neuropsychological symptoms after having been discharged from the hospital.

8 Nov 2020

Psilocybin may be effective in patients suffering from major depression

In a small study of adults with major depression, Johns Hopkins Medicine researchers report that two doses of the psychedelic substance psilocybin, given with supportive psychotherapy, produced rapid and large reductions in depressive symptoms, with most participants showing improvement and half of study participants achieving remission through the four-week follow-up.

4 Nov 2020

Some of the main osteoporosis treatments could have a protective effect against COVID-19

Some of the principal treatments for osteoporosis, denosumab, zoledronate and calcium, could have a protective effect against COVID-19 in patients who take them, specifically a 30 to 40% reduction in the rate of infection, according to the results of a joint study by Hospital del Mar, the Hospital del Mar Medical Research Institute (IMIM), Pompeu Fabra University and the Pere Virgili Health Park.

3 Nov 2020

Brain imaging biomarker may help predict treatment response in patients with psychiatric disorders, study reveals

Cohen Veterans Bioscience, a non-profit research biotech advancing brain health solutions, today announces findings from a study which generates new evidence in support of a critical brain imaging biomarker, that may help guide people who suffer from post-traumatic stress disorder or major depressive disorder towards the most effective treatment.

21 Oct 2020

Meditation and yoga can be a viable option for people seeking chronic pain relief

A mindfulness-based stress reduction (MBSR) course was found to benefit patients with chronic pain and depression, leading to significant improvement in participant perceptions of pain, mood and functional capacity, according to a study in the Journal of the American Osteopathic Association.

1 Oct 2020

Study reveals how subanesthetic ketamine is effective in treating adult amblyopia

In a new study, published in Current Biology, researchers from the University of California, Irvine School of Medicine reveal how subanesthetic ketamine, which is used for pain management and as an antidepressant in humans, is effective in treating adult amblyopia, a brain disorder commonly known as "lazy eye."

30 Sep 2020

First clinical trial launched to test psilocybin therapy for depression in cancer patients

The first clinical trial to test the safety and feasibility of psilocybin therapy with simultaneous administration and one-on-one patient support to treat depression in cancer patients was launched today by Maryland Oncology Hematology at the Aquilino Cancer Center at Adventist HealthCare Shady Grove Medical Center.

16 Sep 2020

Study: Significant proportion of older dental patients inappropriately prescribed opioids

A new study by researchers at the University of Illinois Chicago and the University of Pittsburgh suggests that a significant proportion of older patients receiving opioids at dental visits also use psychotropic medications -- a potentially harmful combination.

16 Sep 2020

Antidepressant News and Research

Further Reading

Healthy gut microbiota contributes to normal brain function, study shows

Researchers assess benefits of magnetic seizure therapy to treat depression in bipolar patients

Antidepressant may prevent worsening of COVID-19 infection, study suggests

Antidepressant drug fluvoxamine may prevent some serious complications of COVID-19

Targeting TAAR5 can provide a new treatment opportunity for neurodegenerative disorders

Delirium common after hospital discharge in critically ill COVID-19 patients

Psilocybin may be effective in patients suffering from major depression

Some of the main osteoporosis treatments could have a protective effect against COVID-19

Brain imaging biomarker may help predict treatment response in patients with psychiatric disorders, study reveals

Meditation and yoga can be a viable option for people seeking chronic pain relief

Study reveals how subanesthetic ketamine is effective in treating adult amblyopia

First clinical trial launched to test psilocybin therapy for depression in cancer patients

Study: Significant proportion of older dental patients inappropriately prescribed opioids

Physical diseases increase risk of being hospitalized with depression

Measuring brainwaves produced during REM sleep can predict patients response to treatment from depression

Measuring heart rate changes to detect depression risk

Study shows possibility to predict who would benefit from exercise and behavioral therapy

Antidepressants are not designed for dementia, shows study

Investigators identify three trajectories of antidepressant dispensing during pregnancy

Botox injections can reduce depression, shows study

Industry Focus eBook - Forensics & toxicology (2nd edition) eBook

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

The impact of vibration on microscopy

How Omics Technologies Are Transforming Biological Research and Drug Discovery

Latest News